Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009-Reference-Cited by-全球学者库

Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009

Published:2013-05 Issue:5 Volume:41 Page:457-462
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Jean Shio-Shin,Hsueh Po-Ren,Lee Wen-Sen,Yu Kwok-Woon,Liao Chun-Hsing,Chang Feng-Yi,Ko Wen-Chien,Wu Jiunn-Jong,Chen Yen-Hsu,Chen Yao-Shen,Liu Jien-Wei,Lu Min-Chi,Liu Cheng-Yi,Lam Carlos,Chen Ray-Jade

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital;Yang;J Clin Microbiol,2012

2. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement;Clinical and Laboratory Standards Institute,2009

3. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement;Clinical and Laboratory Standards Institute,2011

4. Discordance of meropenem versus imipenem activity against Acinetobacter baumannii;Ikonomidis;Int J Antimicrob Agents,2006

5. Breakpoint tables for interpretation of MICs and zone diameters, version 1.3;European Committee on Antimicrobial Susceptibility Testing,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adsorption behavior and antimicrobial activity of new chitosan based functionalized nanocomposites: A case study;2024-02-02

2. In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012–2021;International Journal of Antimicrobial Agents;2023-08

3. Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli;Frontiers in Microbiology;2022-04-18

4. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria;Frontiers in Cellular and Infection Microbiology;2022-03-15

5. Klebsiella pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution over 20 Years, 1998–2019;International Journal of Antimicrobial Agents;2021-07